Try our Advanced Search for more refined results
- Products
- Lexis®
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 In-Depth
- Law360 UK
- Law360 Updates
- Law360 Podcasts
- Beta Tools
- Track docs
- Track attorneys
- Track judges
- Adv. Search & Platform Tools
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Rankings
- Data-Driven Lawyers
- Regional Powerhouses
- Law360's MVPs
- Glass Ceiling Report
- Global 20
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Site Menu
- Join the Law360 team
- Search legal jobs
- Learn more about Law360
- Read testimonials
- Contact Law360
- Sign up for our newsletters
- Site Map
- Help
Shire Development LLC et al v. Watson Pharmaceuticals, Inc. et al
Case Number:
0:12-cv-60862
Court:
Nature of Suit:
Judge:
Firms
- Crowell & Moring
- Genovese Joblove
- Haug Partners LLP
- Knobbe Martens
- Maddox Edwards
- Rasco Klock
- Shutts & Bowen
Companies
Sectors & Industries:
-
March 28, 2016
Actavis' Generic Lialda Still Too Early, Judge Finds
A Florida federal judge on Monday barred Actavis from launching its generic version of Shire’s inflammatory bowel disease treatment Lialda until the patent for the drug expires in June 2020, following a second bench trial on the matter.
-
March 24, 2016
Shire, Actavis Feud Over Unresolved Issues At Lialda IP Trial
A lack of definitive rulings from the Federal Circuit on certain issues in Shire's suit over Actavis' proposed generic version of its gastrointestinal drug Lialda emerged as a major point of contention during closing arguments Wednesday in a Florida federal court, in its second bench trial on the matter.
-
January 25, 2016
Lialda Patent Dispute Seeks Definition In Second Trial
A second bench trial began Monday in Florida in a patent dispute over a generic version of Shire PLC's inflammatory bowel disease treatment Lialda, with the parties offering varying views on the court's task after an appeals court rejected Shire's argument that it applied a review standard incorrectly.
-
May 09, 2013
Shire Blocks Actavis' Generic Lialda Until 2020
A Florida federal judge on Thursday blocked Actavis Inc.'s bid to launch a generic version of Shire PLC's inflammatory bowel disease treatment Lialda, ruling that Shire's patent for the drug was both valid and infringed.
-
March 25, 2013
Watson Can't Skirt Shire's Colitis Drug Patent Suit
A Florida federal judge on Thursday declined to rule outright that Irish drugmaker Shire Development LLC's patent for its ulcerative colitis drug Lialda was invalid, rejecting an attempt by Watson Pharmaceuticals Inc. to have the court clear the way for its generic version of the drug.